ArriVent Biopharma Collaborates with Lepu BioPharma to Develop and Commercialize MRG007 for the Treatment of Gastrointestinal Canc...
Shots: ArriVent & Lepu Biopharma entered into an exclusive license agreement f...
Junshi Biosciences & LEO Pharma Collaborate to Commercialize Toripalimab in Europe
Shots: Junshi with its subsidiary, TopAlliance, has partnered with LEO to market t...
InnoCare and KeyMed Together Partner with Prolium Bioscience to Develop ICP-B02
Shots: InnoCare & KeyMed together have signed an exclusive license agreement w...
Fermion Technology and Simcere Pharma Join Hands to Develop FZ002-037 for Pain Management
Shots: Fermion & Simcere Pharma have entered into an exclusive license and col...
REGENXBIO Join Forces with Nippon Shinyaku to Develop and Commercialize RGX-121 and RGX-111 for Mucopolysaccharidosis (MPS)
Shots: REGENXBIO & Nippon have partnered to develop RGX-121 (Hunter syndrome;...
AbbVie and Simcere Zaiming Collaborate to Develop SIM0500 for Treating Multiple Myeloma
Shots: AbbVie & Simcere Zaiming (subsidiary Simcere Pharma) have signed an opt...
